Genelux's Series C Round

Genelux raised a round of funding on November 11, 2005.

Genelux is a clinical stage biopharmaceutical company with a mission to change the way in which cancer is diagnosed and treated. The company has developed an oncolytic virus-based technology platform …

Articles about Genelux's Series C Round: